chlorambucil has been researched along with tacrolimus in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asano, S; Han, CW; Hashino, S; Imai, K; Imamura, M; Matsudaira, T; Tanaka, J; Zhu, X | 1 |
| Asaka, M; Asano, S; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Matsudaira, T; Tanaka, J; Tao, HR; Zhu, X | 1 |
| Adams, EM; Villalba, L | 1 |
| Kaplan, HJ; Van Gelder, RN | 1 |
| Flores, F; Kerdel, FA | 1 |
| Rosenkrantz, WS | 1 |
| Chen, D; Hu, X; Li, L; Ma, Y; Mao, Z; Mei, C; Sun, L; Xie, G; Xu, C; Xu, J; Yang, L; Ye, C; Zhao, X | 1 |
| Hong, D; Jardine, M; Li, G; Perkovic, V; Ren, S; Toyama, T; Wang, Y; Xian, L | 1 |
7 review(s) available for chlorambucil and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Polymyositis; Tacrolimus | 1996 |
Immunosuppression in uveitis therapy.
Topics: Administration, Oral; Administration, Topical; Animals; Arrestin; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rats; Steroids; Tacrolimus; Uveitis | 1999 |
Other novel immunosuppressants.
Topics: Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Skin Diseases; Tacrolimus; Thioguanine | 2000 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Topics: Adult; Alkylating Agents; Calcineurin Inhibitors; China; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Tacrolimus | 2012 |
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Topics: Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Tolerance; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Randomized Controlled Trials as Topic; Tacrolimus | 2017 |
8 other study(ies) available for chlorambucil and tacrolimus
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
Topics: Animals; Base Sequence; Cells, Cultured; Chlorambucil; Cyclosporine; Cytokines; DNA Primers; Estradiol; Gene Expression Regulation; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Molecular Sequence Data; Polymerase Chain Reaction; RNA, Messenger; Spleen; Tacrolimus | 1995 |
Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Chlorambucil; Colony-Forming Units Assay; Cyclosporine; Estradiol; Hematopoietic Stem Cells; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Tacrolimus | 1995 |